Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are evaluating a new approach to prevent cardiovascular events in people at increased risk due to age and conditions like diabetes, prediabetes, or metabolic syndrome but who do not have symptoms of cardiovascular disease. The study compares a personalized care strategy based on the Cleerly Coronary Artery Disease CAD Staging System with the usual risk factor-based care. This approach aims to better identify and treat individuals with underlying atherosclerosis to reduce cardiovascular events. Participants are randomly assigned to one of two groups. The risk factor-based care group is managed by their usual healthcare providers, with oversight from a centralized cardiology team that monitors treatments and lab results without seeing coronary imaging results. The Cleerly stage-based care group receives personalized management from a remote cardiologist-led team using the Cleerly CAD Staging System, which includes coronary artery imaging, algorithm-driven medication adjustments, and education. Care is intensified if plaque worsens at 24 months. During the study, participants undergo assessments including coronary computed tomography angiography CCTA and lab tests. Researchers monitor cardiovascular events over an average of 3.5 years to compare the two care strategies. Medication use, lab values, and clinical outcomes related to cardiovascular and kidney health are tracked. The study includes electronic communication tools to support personalized care and aims to improve prevention through more precise disease staging and management.
Actively Recruiting
Researchers are conducting the Phase I Human Analytics HALO Study to improve diagnosis and risk prediction for cardiovascular diseases, cancer, dementia, traumatic brain injury, and other disorders. The study uses machine learning and data analysis techniques on electronic medical records to detect subtle patterns, aiming to diagnose diseases earlier and more accurately. The research also focuses on developing multivariate biomarker risk scores and directing participants to relevant clinical trials based on physician review. This observational study involves no interventions and includes groups of patients diagnosed with dementia, prostate cancer, breast cancer, traumatic brain injury, and patients without any diagnosed condition. Data analysis will be applied to all available biomarkers and health determinants to enhance diagnostic confidence and reduce time to diagnosis. Participants are observed over time, with no treatments administered as part of the study. Participants will be monitored through clinical evaluations, biomarker assessments, and data analysis to assess prostate cancer staging, Gleason scores, and mortality over up to five years. Additional outcomes include measurements of urinary symptoms, erectile function, emotional well-being, and incontinence levels. The study collects comprehensive health data to improve diagnosis and risk stratification, with participant involvement lasting several years for long-term monitoring and evaluation.